Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease

Esther Lutgens, Tom T.P. Seijkens

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease'. Together they form a unique fingerprint.

Medicine & Life Sciences